FEB 20, 2017 08:00 AM PST

SPR - Companion from bench to bedside

Speakers
  • Professor, RWTH Aachen University
    Biography
      Markus studied biology at the RWTH Aachen university and joined the group of Rainer Fischer in 1996, then at the department of botany headed by Prof. Kreuzaler where I earned my diploma in biology in 1998 and continued to work at the newly formed department of molecular biology headed by Prof. Fischer. The majority of assays developed were not kinetic assays, but rather the quantification and characterization of various quality attributes of recombinant produced proteins. For almost 20 years, Markus has been in charge of the SPR unit at the Institute for Molecular Biotechnology at the RWTH University and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen. Within this environment SPR is being applied everyday in basic and applied research, from small molecules to antibodies and viruses.

    Abstract:

    SPR technology is being improved steadily and today is an essential component in the biopharmaceutical industry. As SPR based assays extract valuable and reliable information at high accuracy and precision they also provide huge advantages and opportunities for basic and applied research. Progress in synthetic biology and scalable transient gene expression systems is rapidly expanding not only the demand but also increasing the repertoire and quality of reagents for molecular recognition studies. We use SPR assays for a huge variety of tasks within a multi-user facility and are particularly interested in using plant-based systems for the discovery, development and production of biopharmaceuticals. The practical uses and applications to plant-produced antibodies and malaria vaccine development will be illustrated.

    Focusing on protein cocktails, questions addressing their identity, composition, and potency will be discussed. SPR based assays are not only considered to be instrumental to advance such products into the clinic but will play an equally important role for studying their behavior and efficacy in patients.


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    MAY 24, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...